Matching Geography

Reports matching your search in:
 
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!
 

Biotechnology Company Reports

1594

Research your competitors and discover new corporate prospects in the biotechnology industry with company reports and profiles.

RSS Feeds

All reports in Biotechnology Company Reports

< prev 1  2  3  4  5  6  7  8  9  10  next >
Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review
5/16/2012 | published by: GlobalData
... focus is on the development of Eniluracil, an oral dihydropyrimidine dehydrogenase (DPD) inhibitor, which it is developing to improve the tolerability and effectiveness of 5-fluorouracil (5-FU). Eniluracil is in Phase II trial for metastatic breast ...  |  more...
$125.00
Gilead Sciences, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Gilead ...  |  more...
$500.00
Ardea Biosciences, Inc. (RDEA) - Financial and Strategic SWOT Analysis Review
5/11/2012 | published by: GlobalData
... of gout and cancer. The product portfolio of the company includes three pipeline products, namely, Lesinurad (RDEA 594), RDEA 3170 and Bay 86-966 (RDEA 119). Lesinurad and RDEA 3170 are currently in Phase-III and Phase-I ...  |  more...
$125.00
Biotech Financial Reports - May 2012
5/1/2012 | published by: Worldwide Videotex
BIOTECH FINANCIAL REPORTS provides the latest financial information and news on biotech and pharmaceutical companies. This includes quarterly and annual reports plus merger and acquisition news, and stock dividend announcements.  |  more...
$25.00
Novartis Consumer Health, Inc.
5/1/2012 | published by: SGA Lists
... Address (Street, City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for ...  |  more...
$36.00
Celgene Corporation
5/1/2012 | published by: SGA Lists
... Address (Street, City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for ...  |  more...
$107.00
Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
5/1/2012 | published by: Current Partnering
... enter royalty financing deals. Comprehensive directory of royalty financing deals since 2007 Royalty financing contract documents Royalty financing agreement terms Royalty financing agreement structure Top royalty financing deals by value Most active Royalty financing dealmakers  |  more...
$2,695.00
Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
5/1/2012 | published by: Current Partnering
... Revised and updated 6th edition, includes: Trends in co-promotion and co-marketing deals Co-promotion and co-marketing agreement structure Co-promotion and co-marketing contract documents Top co-promotion deals by value Top co-marketing deals by value Most active co-promotion ...  |  more...
$2,695.00
Biotech Business - May 2012
5/1/2012 | published by: Worldwide Videotex
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline.  |  more...
$25.00
Ardea Biosciences, Inc.
5/1/2012 | published by: SGA Lists
... Address (Street, City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for ...  |  more...
$25.00
Biotech Equipment Update - May 2012
5/1/2012 | published by: Worldwide Videotex
... product and technology announcements, as well as vendor research, development, and manufacturing information. Please Note: Due to the brevity and/or nature of the content posted, there is no table of contents available for this report.  |  more...
$25.00
ICON plc
5/1/2012 | published by: SGA Lists
... Address (Street, City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for ...  |  more...
$52.00
Novartis AG
5/1/2012 | published by: SGA Lists
... Address (Street, City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for ...  |  more...
$43.00
Elan Corporation, plc (ELN) - Financial and Strategic SWOT Analysis Review
5/1/2012 | published by: GlobalData
... also involved in research, development, and commercial activities mainly in the field of Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis (MS). In addition, the company focuses on the discovery of antibodies to neo-epitope related targets ...  |  more...
$125.00
Champions Biotechnology, Inc.
5/1/2012 | published by: SGA Lists
... Address (Street, City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for ...  |  more...
$12.00
Worldwide Biotech - May 2012
5/1/2012 | published by: Worldwide Videotex
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry.  |  more...
$25.00
Gilead Sciences, Inc. (GILD) - Financial and Strategic SWOT Analysis Review
4/24/2012 | published by: GlobalData
... product and pipeline portfolio of the company focuses on various therapeutic areas including HIV/AIDS (human immunodeficiency virus/ auto immunodeficiency syndrome), liver, cardiovascular, metabolic, respiratory, infectious diseases, inflammation and oncology. Gilead carries its sales operations through ...  |  more...
$125.00
Dendreon Corporation (DNDN) - Financial and Strategic SWOT Analysis Review
4/17/2012 | published by: GlobalData
... including breast, ovary, lung, colon and bladder cancers. The company has only one marketed product, PROVENGE, for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer. The pipeline products of the company ...  |  more...
$125.00
XOMA Corporation (XOMA) - Financial and Strategic SWOT Analysis Review
4/17/2012 | published by: GlobalData
... autoimmune disorders, infectious diseases and various types of cancer. It has licensed it monoclonal technologies to major biotechnology and pharmaceutical companies for the development of biologics. Leveraging its expertise, technologies, and collaborative agreements it also ...  |  more...
$125.00
Aastrom Biosciences, Inc. (ASTM) - Financial and Strategic SWOT Analysis Review
4/9/2012 | published by: GlobalData
... company’s principal business is to develop innovative cell therapies based products for use in multiple therapeutic areas like, cardiac and vascular. The company’s preclinical and clinical product development programs investigate the ability of patient-derived bone ...  |  more...
$125.00
Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review
4/9/2012 | published by: GlobalData
... products and services to more than 60,000 customers worldwide. In the custom manufacturing products division the company offers various range of bioresearch products, development services and manufacturing for functional and active ingredients. The company operates ...  |  more...
$125.00
Sernova Corp. (SVA) - Financial and Strategic SWOT Analysis Review
4/9/2012 | published by: GlobalData
... number of serious disease indications, starting with a novel treatment for insulin-dependent diabetes, using the novel Cell Pouch System and its patented Sertolin cell technology. The company’s lead project is Sertolin, a technology to reverse ...  |  more...
$125.00
Ablynx NV (ABLX) - Financial and Strategic SWOT Analysis Review
4/9/2012 | published by: GlobalData
... diseases. Nanobodies are a novel class of antibody-derived therapeutic proteins based on antibody fragments consisting of a single monomeric variable antibody domain. It has advantages of conventional antibodies along with the key features of small ...  |  more...
$125.00
Ark Therapeutics Group plc (AKT) - Financial and Strategic SWOT Analysis Review
4/9/2012 | published by: GlobalData
... medicines with focus on vascular disease and cancer. The company’s pipeline product candidates include EG013 for fetal growth restriction, EG011 for refractory angina, EG016 for peripheral vascular disease, Cerepro for malignant glioma, and Trinam for ...  |  more...
$125.00
Global Biotechnology
4/4/2012 | published by: IBISWorld
... products and services. The definition of biotechnology as used by the US Census Bureau and the National Science Foundation is the application of molecular and cellular processes to solve problems, conduct research, and create goods ...  |  more...
$935.00
< prev 1  2  3  4  5  6  7  8  9  10  next >